Team:EPF Lausanne/Calendar/15 August 2013

From 2013.igem.org

(Difference between revisions)
Line 5: Line 5:
''Primer Resuspension'' <BR>
''Primer Resuspension'' <BR>
We recieved our primers and resuspended them. Then we dilluted them in order to have a final concentration of 100umol.
We recieved our primers and resuspended them. Then we dilluted them in order to have a final concentration of 100umol.
 +
<BR>
''Innoculating Bacteria'' <BR>
''Innoculating Bacteria'' <BR>
Line 13: Line 14:
<font size = "4"> Nanoparicles</font> <BR>
<font size = "4"> Nanoparicles</font> <BR>
-
''Making Nanoparticles, 2nd try''<BR>
+
''Making Nanoparticles, 2nd try''
<BR>- The nanoparticles are done.
<BR>- The nanoparticles are done.
<BR>- Characterization of the new gelatin nanoparticles with the DLS : their average size is 160 nm !  
<BR>- Characterization of the new gelatin nanoparticles with the DLS : their average size is 160 nm !  

Revision as of 15:44, 3 October 2013

Taxi.Coli: Smart Drug Delivery iGEM EPFL

Header

Sensing

Primer Resuspension
We recieved our primers and resuspended them. Then we dilluted them in order to have a final concentration of 100umol.

Innoculating Bacteria
From each agar plate that we inncubated over-night we innoculated one colony in order to make a glycerol stock of MMP2 and MMP9 containing bacteria the next day.


Nanoparicles

Making Nanoparticles, 2nd try
- The nanoparticles are done.
- Characterization of the new gelatin nanoparticles with the DLS : their average size is 160 nm !